Summary
A multicentric study of the incidence of pneumococcal serotypes was recently carried out in five different geographical areas in Italy. Two hundred and sixty-seven strains were typed using the quellung reaction with monospecific antisera, but only 28 of these were isolated directly from the site of infection. The most frequent serotypes were 19, 6, 3, 9, 4, 1 and 18 without remarkable differences regarding the area, age of patients and site of isolation. It was found that 60.3% of the serotypes isolated from all sources and 67.8% of those isolated from the sites of infection are contained in the currently used anti-pneumococcal vaccine. Antibiotic resistance was found versus aminoglycosides (34.9%), tetracycline (28.3%), chloramphenicol (5.2%) and penicillin (3.3%). Cefoxitin appeared to be the antibiotic to which the pneumococci were most susceptible. Only two types, 19 and 16, resulted resistant to all the antibiotics.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Appelbaum P. C., Bhamjee A., Scragg J. N., Hallet A. F., Bowen A. J., Cooper R. C.:Streptococcus pneumoniae resistant to penicillin and chloramphenicol — Lancetii, 995, 1977.
Austrian R.: The quellung reaction, a neglected microbiologic technique — Mt Sinai J. Med.43, 699, 1976.
Austrian R.: Pneumococcal infection and pneumococcal vaccine — New Engl. J. Med.297, 938, 1977.
Austrian R., Gold J.: Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia — Ann. intern. Med.60, 759, 1964.
Borcoño J. M., McLean A. A., Vella P. P., Woodhour A. F., Canepa I., DAvidson W. L., Hilleman M. R.: Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants — Proc. Soc. exp. Biol. (N.Y.)157, 148, 1978.
Calder M. A., Hardy V. U., Schonell M. E.: Importance of pneumococcal typing in pneumonia — Lanceti, 5, 1970.
Dixon J. M.:Pneumococcus resistant to erythromycin and lincomycin — Lanceti, 573, 1967.
Finland M.: Editorial — Lancetii, 770, 1978.
Gray B. M., Converse G. M., Dillon H. C.: Serotypes ofStreptococcus pneumoniae causing disease — J. infect. Dis.140, 979, 1979.
Hilleman M. R., McLean A. A., Vella P. P., Weibel R. E., Woodhour A. F.: Polyvalent pneumococcal polysaccharide vaccines — Bull. Wld Hlth Org.56, 371, 1978.
Hince C. J., Howard A. J.: Serotypes ofStreptococcus pneumoniae in the United Kingdom — Curr. Chemother.26, 543, 1978.
Jacobs M. R., Koornhof H. J., Robins-Browne R. M., Stevenson C. M., Vermaak Z. A., Freiman I., Bennie Miller G., Witcome M. A., Isaacson M., Ward J., Austrian R.: Emergence of multiple resistant pneumococci — New Engl. J. Med.299, 735, 1978.
Lund E., Pulverer G., Jeljaszewicz J.: Serological types ofDiplococcus pneumoniae strains isolated in Germany — Med. Microbiol. Immunol.159, 171, 1974.
Norrby S. R., Pope K. A.: Pneumococcal pneumonia — J. Infect.1, 109, 1979.
Study Group on Antibiotic Resistance: Tetracycline resistance in pneumococci and group A streptococci — Brit. med. J.i, 131, 1977.
Weber F., Kayser F. H.: Antibiotic resistance and scrotypes ofStreptococcus pneumoniae in Switzerland — J. Infect.1 (Suppl. 2), 53, 1979.
Weibel R. E., Vella P. P., McLean A. A., Woodhour A. F., Davidson W. L., Hilleman M. R.: Studies in human subjects of polyvalent pneumococcal vaccines — Proc. Soc. exp. Biol. (N.Y.)156, 144, 1977.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Bac, C., Andreoni, O., Fara, G.M. et al. A multicentric study for serotyping and susceptibility to antibiotics of pneumococci in Italy. La Ricerca Clin. Lab. 11, 145–149 (1981). https://doi.org/10.1007/BF02886714
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02886714